Latest News

Investors cheer CSL result and outlook August 16, 2018

CSL (ASX:CSL) has reported net profit after tax of $1.729 billion for the twelve months ended 30 June 2018, an increase of 29 percent on the previous year, a result "slightly ahead" of the most recent guidance.

Report released on review of food using new breeding techniques August 16, 2018

AusBiotech’s submission to the Food Standards Australia New Zealand (FSANZ) consultation on 'Food derived using new breeding techniques' has formed part of a newly-released Preliminary Report summarising the submissions.

CSIRO announces new chief scientist August 16, 2018

Dr Foley is a world-renowned physicist and science leader most noted for her work developing superconducting devices and systems that have assisted in unearthing over $6 billion in minerals worldwide.

FDA approval for Pharmaxis manufacturing facility August 16, 2018

Sydney-based Pharmaxis (ASX:PXS) has received approval from the US FDA for its manufacturing facility to produce the asthma diagnostic product Aridol for the US market.

Government announces $200m in new medical research grants August 16, 2018

Health minister Greg Hunt has announced $200 million in new medical research projects.

Acrux first-to-file first generic in the US August 14, 2018

The company said its ANDA contains the required data that allows it to demonstrate to the FDA its generic product is bioequivalent to Jublia.

AbbVie invests in northern QLD biotech August 14, 2018

AbbVie Ventures, Brandon Capital’s Medical Research Commercialisation Fund (MRCF) and OneVentures have announced a $6 million investment into new biotechnology company Paragen Bio.

AusBiotech welcomes Anna Lavelle's new appointment August 14, 2018

AusBiotech has welcomed the appointment of its former CEO, Dr Anna Lavelle, as the new chair of Medicines Australia.

Cochlear reports record profit and 500,000th implant sale August 14, 2018

The company reported net profit of $245.8 million, an increase of 10 percent on the previous year, and said it expects that to rise to $265-275 million in FY19.

Adherium launches 'Hailie' in the US August 13, 2018

Adherium (ASX:ADR) has officially launched its Hailie solution in the US following its recent approval by the Food and Drug Administration for over-the-counter sales direct to consumers.

Ex-Roche executive to lead QIMR spin-out August 9, 2018

genomiQa, a start-up company originating from QIMR Berghofer Medical Research Institute in Brisbane, has appointed an ex-senior Roche executive as its new CEO.

G Medical to spin-off Chinese subsidiary August 9, 2018

Mobile and e-Health company G Medical Innovations (ASX:GMV) has announced a plan to list its Chinese subsidiary, Guangzhou Yimei Innovative Medical Science and Technology, on the main board of The Stock Exchange of Hong Kong.

Most Read

Government announces $200m in new medical research grants

CSIRO announces new chief scientist

Investors cheer CSL result and outlook

Report released on review of food using new breeding techniques

FDA approval for Pharmaxis manufacturing facility

New Stories

Investors cheer CSL result and outlook

Report released on review of food using new breeding techniques

CSIRO announces new chief scientist

FDA approval for Pharmaxis manufacturing facility

Government announces $200m in new medical research grants

Acrux first-to-file first generic in the US

AbbVie invests in northern QLD biotech

Sign In

Most Read

Government announces $200m in new medical research grants

CSIRO announces new chief scientist

Investors cheer CSL result and outlook

Report released on review of food using new breeding techniques

FDA approval for Pharmaxis manufacturing facility

Follow Us

New Stories

Investors cheer CSL result and outlook

Report released on review of food using new breeding techniques

CSIRO announces new chief scientist

FDA approval for Pharmaxis manufacturing facility

Government announces $200m in new medical research grants

Acrux first-to-file first generic in the US

AbbVie invests in northern QLD biotech